Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty

Trial Profile

Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral ischaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2016 Planned primary completion date changed from 1 Jun 2020 to 1 Aug 2020.
    • 29 Sep 2016 Status changed from not yet recruiting to recruiting.
    • 05 Jul 2016 Age criteria for the patients has been changed from 18-85 to 40-95 Years.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top